At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Corporate Governance >> Insider Transactions

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Dec 3, 2007 dentzer james e Officer Disposition (Non Open Market) 220 15.30
Feb 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.24
Apr 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 11.49
Jul 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.81
Jun 2, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.20
May 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 10.81
Mar 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 9.85
Aug 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 15.61
Sep 2, 2008 dentzer james e Officer Disposition (Non Open Market) 220 13.86
Oct 1, 2008 dentzer james e Officer Disposition (Non Open Market) 220 15.10
Nov 4, 2009 barer sol j Director Buy 20,000 4.13
Mar 15, 2013 barer sol j Director Buy 25,000 3.40
Mar 7, 2012 barrett m james Director Buy 925,154 5.70
Mar 7, 2012 barris peter j Beneficial Owner (10% or more) Buy 1,140,000 5.70
Jun 17, 2011 crowley john f Officer Buy 20,000 6.04
Aug 11, 2011 crowley john f Officer Buy 10,000 4.20
Mar 2, 2010 crowley john f Officer Buy 11,898 3.69
Feb 20, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 49,500 9.50 - 9.82
Feb 27, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 14,700 9.65 - 9.94
Feb 27, 2008 fhm iv lp Beneficial Owner (10% or more) Buy 8,600 9.95 - 10.18
Showing 81-100 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.


Copyright © 2012 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy